CXXI Valuation vs Cresco Labs acquiring TrykeCresco Labs has just announced the acquisition of Tryke for US$282.5 million. Tryke has revenue of US$70.4 million and US$24.6 million EBITDA. Tryke is valued at 4X revenue and 11.5X EBITDA. CXXI had Q2 revenue of US$9.9 million and is growing strongly. Say we conservatively we put annual revenue at US$40 million annum. You can do the math that that CXXI is worth north of C$2. As I keep saying there will be a deal done to fix the balance sheet and to re-start acquisitions now that the core assets are operating well. This company has great assets. CXXI SP is now too cheap not have people pitching deals at the company.